[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, multiple studies have shown that elevated levels of calprotectin in stool samples can predict a relapse in inflammatory bowel disease (IBD) patients. These studies have been conducted in both Crohn's disease (CD) and ulcerative colitis (UC) patients. Calprotectin levels have been found to correlate with endoscopic activity, mucosal healing, and disease activity. Additionally, measuring calprotectin levels every third month has been shown to be informative in predicting relapse in IBD patients. Therefore, the answer to the question is A. yes, calprotectin can predict relapse risk in inflammatory bowel disease.\", \"answer_choice\": \"A\"}"
]